Douglas J. Hughes serves as Executive at Immunovant, Inc., where they oversee executive responsibilities. Since joining the company, Douglas J. Hughes has executed 12 insider transactions totaling $581.5K, demonstrating a bearish approach to their equity position. Their most recent transaction on Dec 1, 2025 involved selling 1,909 shares valued at $45.7K.
Douglas J. Hughes currently holds 120,773 shares of Immunovant, Inc. (IMVT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Douglas J. Hughes has been a net seller of IMVT stock. They have purchased $150.4K and sold $431.2K worth of shares.
Douglas J. Hughes's most recent insider trade was on Dec 1, 2025, when they sold 1,909 shares at $23.96 per share.
Get notified when new Form 4 filings are submitted
| $23.14 |
| Discretionary |
| Apr 2, 2024 | IMVT | $0 | Award | 11,255 | $N/A | Discretionary |
| Apr 12, 2023 | IMVT | $0 | Award | 12,523 | $N/A | Discretionary |
| Nov 22, 2022 | EAR | $35.7K | Exercise | 71,363 | $0.50 | Discretionary |
| Aug 17, 2022 | IMVT | $0 | Award | 21,059 | $N/A | Discretionary |
| Jan 10, 2022 | IMVT | $0 | Award | 21,726 | $N/A | Discretionary |
| Aug 27, 2021 | IMVT | $150.4K | Purchase | 18,247 | $8.24 | Discretionary |
| Apr 27, 2021 | EAR | $82.5K | Sale | 1,500 | $55.00 | Discretionary |
| Mar 19, 2021 | IMVT | $0 | Award | 15,500 | $N/A | Discretionary |
| Oct 20, 2020 | EAR | $0 | Conversion | 37,209 | $N/A | Discretionary |
| May 15, 2020 | IMVT | $0 | Award | 24,700 | $N/A | Discretionary |